Polymorphic and amorphous forms of 2,5-Dimethyl-2H-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((e)-2-pyridin-2-yl-vinyl)-1 H-indasol-6-ylamino]-phenyl}-amide

Details for Australian Patent Application No. 2005223486 (hide)

Owner Pfizer Inc.

Inventors Wightlin, Matthew David; Hettinger, Donald Nicholas; Saeed, Nabil Lauze; Mitchell, Mark Bryan; Srirangam, Jayaram Kasturi; Kania, Robert Steven; Ye, Qiang; Zook, Scott Edward; Ouellette, Michael Allen

Agent Allens Arthur Robinson

Pub. Number AU-A-2005223486

PCT Pub. Number WO2005/090331

Priority 60/554,140 17.03.04 US

Filing date 4 March 2005

Wipo publication date 29 September 2005

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/090331 Priority application(s): WO2005/090331

26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223488-Phenylethanolamine derivatives as Beta-2 agonists

2005223483-N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides